Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Current Assets (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Current Assets for 6 consecutive years, with $61.2 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 24.41% to $61.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.2 million through Dec 2025, down 24.41% year-over-year, with the annual reading at $61.2 million for FY2025, 24.41% down from the prior year.
  • Current Assets hit $61.2 million in Q4 2025 for Rapid Micro Biosystems, down from $70.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $244.2 million in Q3 2021 to a low of $60.1 million in Q2 2025.
  • Historically, Current Assets has averaged $123.9 million across 5 years, with a median of $118.0 million in 2021.
  • Biggest five-year swings in Current Assets: soared 250.96% in 2021 and later tumbled 40.79% in 2022.
  • Year by year, Current Assets stood at $218.1 million in 2021, then crashed by 36.47% to $138.6 million in 2022, then fell by 13.11% to $120.4 million in 2023, then crashed by 32.8% to $80.9 million in 2024, then fell by 24.41% to $61.2 million in 2025.
  • Business Quant data shows Current Assets for RPID at $61.2 million in Q4 2025, $70.0 million in Q3 2025, and $60.1 million in Q2 2025.